New device aims to solve feeding problems in ICU patients with organ failure
NCT ID NCT05710315
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests whether a device called RELiZORB™ can help critically ill adults with multiple organ failure better tolerate tube feedings. The device breaks down fats in the feeding to make them easier to digest. Researchers will compare how well patients meet their nutrition goals over five days with or without the device.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXOCRINE PANCREATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inova Fairfax Medical Campus
Falls Church, Virginia, 22042, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- European registry aims to improve care for pancreatic enzyme deficiency
- CF breakthrough: kids may ditch daily enzyme pills after modulator treatment
- New pill aims to help cystic fibrosis patients digest food
- New MRI study aims to spot pancreas trouble early
- New blood test could spot hidden digestive problems in pancreatitis patients
- Pancreas transplant weight gain mystery: is extra digestive juice to blame?